Negative regulation of early polyomavirus expression in mouse embryonal carcinoma cells

Journal of Virology
|September 1, 1986
PubMed

Insights

Embryonal carcinoma cells resist polyomavirus (Py) infection. Inhibiting protein synthesis or coinfecting with simian virus 40 partially overcomes this, suggesting a labile protein blocks early Py transcription.

Area of Science:

  • Virology
  • Molecular Biology
  • Cell Biology

Background:

  • Embryonal carcinoma (EC) cells exhibit resistance to polyomavirus (Py) infection.
  • Understanding the molecular mechanisms underlying this resistance is crucial for viral pathogenesis studies.

Purpose of the Study:

  • To investigate the factors contributing to polyomavirus infection resistance in embryonal carcinoma cells.
  • To identify strategies for overcoming this cellular defense mechanism.

Main Methods:

  • Treatment of infected cells with cycloheximide to inhibit protein synthesis.
  • Coinfection experiments with polyomavirus and simian virus 40.
  • Analysis of T-antigen expression in Py-infected PCC4 embryonal carcinoma cells under various conditions.

Main Results:

  • Temporary inhibition of protein synthesis partially removed the infection block.
  • Coinfection with simian virus 40 also partially alleviated the resistance.
  • Cycloheximide treatment of cells infected with specific Py mutants resulted in a 3- to 10-fold increase in T-antigen-positive cells.
  • Enhanced Py T-antigen expression was observed at 31°C upon cycloheximide treatment.

Conclusions:

  • PCC4 embryonal carcinoma cells likely synthesize a labile regulatory protein that inhibits early Py transcription.
  • This protein may bind to noncoding sequences, including enhancer elements A and B, thus preventing viral gene expression.
  • Py mutants used in this study appear to retain binding sites for this inhibitory protein.